Chao Lu

802 total citations
35 papers, 593 citations indexed

About

Chao Lu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Chao Lu has authored 35 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Cancer Research and 7 papers in Immunology. Recurrent topics in Chao Lu's work include Cancer-related molecular mechanisms research (4 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Renal Diseases and Glomerulopathies (3 papers). Chao Lu is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), Bladder and Urothelial Cancer Treatments (4 papers) and Renal Diseases and Glomerulopathies (3 papers). Chao Lu collaborates with scholars based in China, Canada and United States. Chao Lu's co-authors include Guoping Zhou, Sheng‐Hua Wu, Ling Dong, Timothy Winton, James R. Woodgett, Dennis A. Wigle, Shaf Keshavjee, Michael Johnston, Frances A. Shepherd and Ni Liu and has published in prestigious journals such as Kidney International, Archives of Biochemistry and Biophysics and Gene.

In The Last Decade

Chao Lu

34 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chao Lu China 13 337 187 116 68 67 35 593
Peng Du China 17 463 1.4× 364 1.9× 131 1.1× 69 1.0× 91 1.4× 50 832
Zihao Chen China 13 400 1.2× 134 0.7× 108 0.9× 46 0.7× 49 0.7× 40 604
Yunchao Deng China 12 255 0.8× 110 0.6× 110 0.9× 50 0.7× 68 1.0× 26 530
Xutao Lin China 17 346 1.0× 220 1.2× 81 0.7× 80 1.2× 151 2.3× 47 716
Endre Kálmán Hungary 13 232 0.7× 181 1.0× 93 0.8× 66 1.0× 89 1.3× 56 647
Qi Wan China 15 401 1.2× 199 1.1× 121 1.0× 96 1.4× 62 0.9× 58 751
Yanan Wang China 16 472 1.4× 357 1.9× 94 0.8× 69 1.0× 35 0.5× 55 716
Xiaolin Lin China 15 388 1.2× 240 1.3× 64 0.6× 60 0.9× 39 0.6× 31 579
Maryam Moradi Binabaj Iran 14 314 0.9× 177 0.9× 102 0.9× 67 1.0× 40 0.6× 30 655
Andrea G. Kahn United States 13 197 0.6× 81 0.4× 140 1.2× 54 0.8× 97 1.4× 35 625

Countries citing papers authored by Chao Lu

Since Specialization
Citations

This map shows the geographic impact of Chao Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Lu more than expected).

Fields of papers citing papers by Chao Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Lu. The network helps show where Chao Lu may publish in the future.

Co-authorship network of co-authors of Chao Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Chao Lu. A scholar is included among the top collaborators of Chao Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao Lu. Chao Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ni, Rui, Xiaoyun Ji, Ting Cao, et al.. (2024). Nicotinamide mononucleotide protects septic hearts in mice via preventing cyclophilin F modification and lysosomal dysfunction. Acta Pharmacologica Sinica. 46(4). 976–988. 7 indexed citations
2.
Mi, Yuanyuan, Yangyang Sun, Bowen Tang, et al.. (2022). Associations of Genetic Polymorphisms of mTOR rs2295080 T/G and rs1883965 G/A with Susceptibility of Urinary System Cancers. Disease Markers. 2022. 1–16. 4 indexed citations
3.
Lu, Chao, et al.. (2021). Clinical effect of Brisson operation modified by Y-shaped incision for treatment of concealed penis in adolescents. Journal of International Medical Research. 49(4). 3619066879–3619066879. 1 indexed citations
4.
Lu, Chao, Shuai Gao, Peng Zhang, et al.. (2021). Two types of immune infiltrating cells and six hub genes can predict the occurrence of myasthenia gravis in patients with thymoma. Bioengineered. 12(1). 5004–5016. 4 indexed citations
5.
Chen, Yuan, et al.. (2021). Imbalance of Th17 and Tregs in thymoma may be a pathological mechanism of myasthenia gravis. Molecular Immunology. 133. 67–76. 16 indexed citations
6.
Lu, Chao, et al.. (2021). Comparing Prognosis Associated with Partial Cystectomy and Trimodal Therapy for Muscle-Invasive Bladder Cancer Patients. Urologia Internationalis. 107(1). 46–57. 3 indexed citations
7.
Wu, Hao, et al.. (2021). Exosome-Derived Long Non-Coding RNAs as Non-Invasive Biomarkers of Bladder Cancer. Frontiers in Oncology. 11. 719863–719863. 11 indexed citations
8.
Hui, Qi, Chao Lu, Jianing Bi, et al.. (2020). Validation of a Double-Sandwich Enzyme-Linked Immunoassay for Pharmacokinetic Study of an rh-aFGF Hydrogel in Rat Skin and Serum. Frontiers in Pharmacology. 11. 700–700. 2 indexed citations
10.
Zhang, Yu, Jichun Liu, Jianjun Xu, et al.. (2019). Biofunctionalization of decellularized porcine aortic valve with OPG-loaded PCL nanoparticles for anti-calcification. RSC Advances. 9(21). 11882–11893. 12 indexed citations
11.
Zhang, Lin, Hong‐Gui Xu, & Chao Lu. (2013). A novel long non-coding RNA T-ALL-R-LncR1 knockdown and Par-4 cooperate to induce cellular apoptosis in T-cell acute lymphoblastic leukemia cells. Leukemia & lymphoma. 55(6). 1373–1382. 28 indexed citations
12.
Ren, Wei, Hua‐Guo Xu, Chao Lu, et al.. (2010). The characterization of two novel IRF-3 transcripts starting from intron 2 of the wild type of IRF-3. Molecular Biology Reports. 38(7). 4415–4421. 5 indexed citations
13.
Xu, Hua‐Guo, et al.. (2009). Characterization of the human IRF-3 promoter and its regulation by the transcription factor E2F1. Molecular Biology Reports. 37(7). 3073–3080. 16 indexed citations
15.
Ren, Wei, et al.. (2008). Functional Characterization of the Regulatory Region of Human CD2-Associated Protein Promoter in HEK 293 Cells. American Journal of Nephrology. 29(3). 203–212. 4 indexed citations
16.
Lu, Chao, et al.. (2008). CREB and Sp1 regulate the human CD2AP gene promoter activity in renal tubular epithelial cells. Archives of Biochemistry and Biophysics. 474(1). 143–149. 8 indexed citations
17.
Lu, Chao. (2006). Effects of mast cell tryptase on the expression of stem cell factor in endothelial cell line and its mechanism. 1 indexed citations
18.
Wu, Sheng‐Hua, et al.. (2005). Lipoxin A4 inhibits TNF-α-induced production of interleukins and proliferation of rat mesangial cells. Kidney International. 68(1). 35–46. 52 indexed citations
19.
Wu, Sheng‐Hua, et al.. (2005). High dose of lipoxin A4 induces apoptosis in rat renal interstitial fibroblasts. Prostaglandins Leukotrienes and Essential Fatty Acids. 73(2). 127–137. 17 indexed citations
20.
Howell, Brandon G., Nowell Solish, Chao Lu, et al.. (2005). Microarray profiles of human basal cell carcinoma: Insights into tumor growth and behavior. Journal of Dermatological Science. 39(1). 39–51. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026